|1.||Braulke, Thomas: 4 articles (11/2013 - 10/2006)|
|2.||Jalanko, Anu: 3 articles (11/2013 - 06/2004)|
|3.||Mole, Sara E: 3 articles (06/2012 - 02/2002)|
|4.||Goebel, Hans H: 2 articles (10/2015 - 11/2013)|
|5.||Simonati, Alessandro: 2 articles (11/2013 - 02/2007)|
|6.||Tyynelä, Jaana: 2 articles (11/2013 - 08/2008)|
|7.||Bigini, Paolo: 2 articles (06/2012 - 01/2011)|
|8.||Mennini, Tiziana: 2 articles (06/2012 - 01/2011)|
|9.||Kida, E: 2 articles (01/2001 - 01/2001)|
|10.||Golabek, A A: 2 articles (01/2001 - 01/2001)|
|1.||Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
01/01/1989 - "Lectin histochemical study of lipopigments with special regard to neuronal ceroid-lipofuscinosis. "
01/01/1983 - "The study reports characteristics of the autofluorescence emission spectra from abnormal accumulations of intraneuronal lipopigment in a case of adult-onset neuronal ceroidosis (Kufs' disease). "
01/01/1981 - "Studies in neuronal ceroid-lipofuscinosis: heterogeneous nature of neuronal autofluorescent lipopigments."
10/01/2015 - "The neuronal ceroid lipofuscinoses (NCL) currently encompass fourteen genetically different forms, CLN1 to CLN14, but are all morphologically marked by loss of nerve cells, particularly in the cerebral and cerebellar cortices, and the cerebral and extracerebral formation of lipopigments. "
07/01/2012 - "Cardiac involvement and accumulation of lipopigments in the myocardium and cardiac conduction system have been recognized in juvenile neuronal ceroid lipofuscinosis, but this is the first report to describe progressive conduction defects in a case of late infantile neuronal ceroid lipofuscinosis."
|2.||Alzheimer Disease (Alzheimer's Disease)
01/01/1990 - "Studies performed on control aging brains and Alzheimer's disease (AD) brains confirmed previous observations of immunoreactivity being found diffusely in the protein component of some neurons containing lipopigment.(ABSTRACT TRUNCATED AT 250 WORDS)"
11/01/1995 - "Alzheimer's disease: distribution of changes in intraneuronal lipopigment in the frontal cortex."
07/01/1992 - "Changes in intraneuronal lipopigment in Alzheimer's disease."
03/01/1989 - "This implicates that, unlike in Alzheimer's disease where this protein is also processed extraneuronally in a manner to release an amyloid fiber forming fragment, the end point of its processing in the nerve cell seems to accumulate on a lipopigment characteristic for normal aging."
|3.||Metachromatic Leukodystrophy (Sulfatide Lipidosis)
01/01/1989 - "Abnormal lipopigments and lysosomal residual bodies in metachromatic leukodystrophy."
01/01/1980 - "Ultrastructural studies on the central and peripheral nervous system of 2 patients with adult onset metachromatic leukodystrophy (MLD), dead at the ages of 46 and 51 years, showed MLD-specific inclusions, tufaceous and prismatic structures, a wide spectrum of membranous arrangements within lysosomal residual bodies, and the intimate admixture of sulfatides and other membranous material with lipopigments. "
|4.||Neurodegenerative Diseases (Neurodegenerative Disease)
06/05/1995 - "This neurodegenerative disease appears associated with the disease process rather than storage of fluorescent lipopigment per se, and there is now growing evidence that pathogenesis may involve mitochondria rather than a primary defect of lysosomal catabolism. "
01/01/2005 - "Neuronal ceroid lipofuscinoses (NCLs) are inherited neurodegenerative diseases characterized by accumulations of autofluorescent lipopigments within cells of the nervous system. "
06/15/2004 - "Neuronal ceroid lipofuscinoses (NCLs) are a group of childhood-onset neurodegenerative disorders characterized by accumulation of autofluorescent lipopigment in many tissues, especially in neurons. "
02/01/2002 - "The neuronal ceroid lipofuscinoses (NCLs) are a group of autosomal recessive neurodegenerative diseases characterized by the accumulation of autofluorescent lipopigment in various tissues and by progressive cell death in the brain and retina. "
07/01/2001 - "Neuronal ceroid lipofuscinoses (NCLs) represent a large group of inherited neurodegenerative disorders characterized by an abnormal accumulation of lipopigment in neuronal and extraneuronal cells. "
11/01/2013 - "Their morphology is marked by: (i) loss of neurons, foremost in the cerebral and cerebellar cortices resulting in cerebral and cerebellar atrophy; (ii) an almost ubiquitous accumulation of lipopigments in nerve cells, but also in extracerebral tissues. "
02/01/1997 - "Morphologic pathology in NCL is marked by two processes, the interaction of which has not yet been completely clarified: 1) degeneration of nerve cells, foremost in the cerebral cortex, resulting in considerable cerebral atrophy in early childhood forms, likely responsible for clinical and neuroradiological findings; 2) widespread accumulation of autofluorescent lysosomal lipopigments of varying ultrastructure, the demonstration of which is still largely responsible for diagnostic recognition of an individual patient's NCL. "
09/01/1994 - "Pathological findings, preference of type 1 muscle fibre atrophy and lipopigment accumulation within the capillary endothelium of the spinal cord of all cases, supported the hypothesis of EMND being an oxidative disease.(ABSTRACT TRUNCATED AT 250 WORDS)"
11/01/1984 - "In addition, there was neuronal storage of lipopigment diffusely throughout the CNS and the autonomic neurons, with cell distention, atrophy, and loss in selected areas."
05/01/2002 - "At necropsy there was severe cerebrocortical atrophy associated with neuronal loss, astrocytosis and the presence in neurons of eosinophilic intracytoplasmic storage bodies with the characteristics of a lipopigment. "
|7.||Sphingolipid Activator Proteins